Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arka Bagchi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Progress in Molecular Biology and Translational Science|February 19, 2026
Fecal microbiota transplantation in liver diseases: Therapeutic potential and associated risksJayeeta Bhowmick, Arka Bagchi
Scientific Reports|March 31, 2025
A multifaceted examination of the action of PDE4 inhibitor rolipram on MMP2/9 reveals therapeutic implicationsArka Bagchi, Analabha Roy, Anindya Halder, et al.
The Journal of Biological Chemistry|January 29, 2025
PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancerArka Bagchi, Anuran Bhattacharya, Analava Bera, et al.
Life Sciences|June 19, 2024
Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinasesAnindita Bhattacharjee, Arka Bagchi, Solanki Sarkar, et al.
ACS Applied Bio Materials|December 27, 2023
Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer ActivityDurga Mondal, Arka Bagchi, Sima Biswas, et al.
Journal of Cellular Biochemistry|September 5, 2022
PDE4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTORPritha Mukherjee, Arka Bagchi, Ananya Banerjee, et al.
ACS Applied Bio Materials|April 6, 2026
Correction to "Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity"Durga Mondal, Arka Bagchi, Sima Biswas, et al.
Chemistry, an Asian Journal|January 28, 2026
Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio-ReceptorsSharmistha Chatterjee, Saikat Mandal, Chandrika Das, et al.
Scientific Reports|July 2, 2025
In-silico drug repositioning studies of Candida albicans Nitrogen permease reactivator 1 (Npr1) kinaseSanjib Das, Arka Bagchi, Analava Bera, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Progress in Molecular Biology and Translational Science|February 19, 2026
Fecal microbiota transplantation in liver diseases: Therapeutic potential and associated risksJayeeta Bhowmick, Arka Bagchi
Scientific Reports|March 31, 2025
A multifaceted examination of the action of PDE4 inhibitor rolipram on MMP2/9 reveals therapeutic implicationsArka Bagchi, Analabha Roy, Anindya Halder, et al.
The Journal of Biological Chemistry|January 29, 2025
PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancerArka Bagchi, Anuran Bhattacharya, Analava Bera, et al.
Life Sciences|June 19, 2024
Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinasesAnindita Bhattacharjee, Arka Bagchi, Solanki Sarkar, et al.
ACS Applied Bio Materials|December 27, 2023
Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer ActivityDurga Mondal, Arka Bagchi, Sima Biswas, et al.
Journal of Cellular Biochemistry|September 5, 2022
PDE4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTORPritha Mukherjee, Arka Bagchi, Ananya Banerjee, et al.
ACS Applied Bio Materials|April 6, 2026
Correction to "Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity"Durga Mondal, Arka Bagchi, Sima Biswas, et al.
Chemistry, an Asian Journal|January 28, 2026
Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio-ReceptorsSharmistha Chatterjee, Saikat Mandal, Chandrika Das, et al.
Scientific Reports|July 2, 2025
In-silico drug repositioning studies of Candida albicans Nitrogen permease reactivator 1 (Npr1) kinaseSanjib Das, Arka Bagchi, Analava Bera, et al.
Pageof 1